"What" Series

What is Active Pharmaceutical Ingredient?

29 March 2024
2 min read

Active Pharmaceutical Ingredient (API) refers to the main substance in a drug that provides the therapeutic effect. It is the chemical component responsible for the drug's efficacy and is the primary constituent that interacts with the body to treat, prevent, or diagnose a disease or condition.

Key points about APIs include:

·Therapeutic Effect: The API is the key player in producing the desired medicinal effect and is carefully selected or designed to interact with biological targets, such as enzymes, receptors, or proteins.

·Formulation: APIs are often combined with other substances, known as excipients, to create the final dosage form of a medication, such as tablets, capsules, or injections.

·Purity and Quality: The purity and quality of APIs are critical to ensure the safety and efficacy of the final drug product. Manufacturing APIs requires strict adherence to quality control and regulatory standards.

·Regulation: APIs are subject to regulatory oversight to ensure they meet the required standards for safety, efficacy, and quality. Regulatory authorities, such as the U.S. Food and Drug Administration (FDA), evaluate and approve APIs before they can be used in medications.

·Development: The development of a new API involves extensive research and testing to discover or synthesize a compound with the desired therapeutic properties and to determine the appropriate dosage and administration method.

·Patents: Many APIs are protected by patents, which give the developer exclusive rights to produce and market the API for a certain period, allowing for recovery of the research and development costs.

APIs are the basis for the pharmaceutical industry, and their discovery and optimization are central to the development of new medicines.

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

AbbVie's Acquisition of Landos Biopharma Bolsters Inflammatory and Autoimmune Treatment Portfolio
Latest Hotspot
3 min read
AbbVie's Acquisition of Landos Biopharma Bolsters Inflammatory and Autoimmune Treatment Portfolio
29 March 2024
AbbVie Plans to Take Over Landos Biopharma, Enhancing Its Collection of Treatments for Inflammation and Autoimmunity.
Read →
Making the Most Out of Synapse: Searching for Nystatin
Drug Insights
2 min read
Making the Most Out of Synapse: Searching for Nystatin
29 March 2024
Nystatin, a minuscule molecule drug with a penchant for functioning as an ergosterol binder, engages in targeting fungal cells, blocking their growth and replication.
Read →
Ferrer and Verge Genomics Partner to Advance ALS Experimental Treatment VRG50635 to Clinical Trials
Latest Hotspot
3 min read
Ferrer and Verge Genomics Partner to Advance ALS Experimental Treatment VRG50635 to Clinical Trials
28 March 2024
Ferrer and Verge Genomics have entered into a collaboration to jointly advance the experimental treatment for ALS, designated as VRG50635, into clinical trials.
Read →
What is Phagocytosis?
"What" Series
2 min read
What is Phagocytosis?
28 March 2024
Phagocytosis is an essential immune response where phagocytes consume foreign particles, dead cells, and pathogens like bacteria and viruses.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.